What is the prospect of Novartis? Which is his fist product?

Novartis is the top five multinational company in the global pharmaceutical industry, headquartered in Basel, Switzerland, with a history of more than 200 years, including its predecessor. Novartis has invested more than 700 million US dollars in China, paying special attention to research and development, and has R&D centers in Shanghai and Changshu. Artemisinin, an antimalarial drug supported by China in Africa, is the result of cooperation between Novartis and the government. Many products of Novartis are listed in China, such as Dai Wen, Lotensin, Lasker, Gleevec, Rexieli and Votaline. Among them, the patent of Votaline has expired, and all kinds of Votaline on the market are Novartis formula, and the patent period of Dai Wen is about to expire.